ICGEB

Congratulations to Dr. Thi Van Anh Vu, Cardiovascular Biology Lab at #ICGEBTrieste, who successfully defended her PhD viva today with The Open University! #icgebalumna #icgebalumni #PhD #phdvivavoce Serena Zacchigna Jenny Molloy

Non-profit organisation Beneficial Bio is one of the eight case studies in the new UK Research and Innovation Engineering Biology Showcase. Congratulations ICGEB Group Leader Biomanufacturing, Jenny Molloy - Executive Director Beneficial Bio - a network of social enterprises run by #biologists whose goal is to help labs around the world secure reagents quickly and economically. #Biomanufacturing #ScienceforDevelopment 👉 https://lnkd.in/dYU39bdQ

Interested in opportunities to support African women in Science? In partnership with the South African Department of Science, Technology and Innovation join the ICGEB DSTI session on 5 December 2024 at the Science Forum South Africa #SFSA2024 (Pretoria) to learn more about our activities & opportunities for #womeninscience Register to attend: https://lnkd.in/dqQjhXQw Luiz Fernando Zerbini Nadine Tambwe Mmampei Chaba Modikoe Patjane Lukovi Seke Nyaradzo Chigorimbo-Tsikiwa Science Diplomacy Capital for Africa

Are we on track to end new infections of HIV? This week, Chris Smith speaks with Haywood Dikibo; Richard Angell OBE from Terrence Higgins Trust; Andrew Grulich at UNSW; Salim Abdool Karim at CAPRISA at the University of KwaZulu-Natal; and Boghuma Titanji at Emory University. This programme was produced by Nadine Tambwe with the support of the ICGEB.

Boosting Biomanufacturing in Africa From 18-29 November 2024, selected participants from 4 regions (and 10 countries) in Africa will receive personalised training in bioprocessing techniques in the Biotechnology Development Unit at ICGEB in Trieste, Italy. Focusing on insight and experience in Good Manufacturing Practices in the biopharmaceutical industry and product-oriented training processes, the course will contribute to consolidating knowledge infrastructure and health research in Africa. Participants are based at the European & Developing Countries Clinical Trials Partnership EDCTP Regional Networks of Excellence. Funded by NIHR, supported by the EU and with international development funding from the UK Government, Department of Health and Social Care. 👉 https://lnkd.in/eP7U6qP9 #biopharmaceuticals #biotech #healthcare

It was a great pleasure having been able to participate at the official presentation of CSAIA - Centro Studi Avanzati per l'Intelligenza Artificiale by its president Pier Paolo Maria Menchetti in the amazingly beautiful setting of the Sala del Refettorio at the Library of our Government Camera dei deputati in Rome. A special thank should go to our gracious host Hon. Giorgio Mulé, Vice-President of the Camera dei Deputati for his inspiring opening of the meeting and to all the many participants who contributed their view on all the great changes this new technology will bring to all aspects of our lives, in the not too distant future. ICGEB

Vacancy Alert: @New Delhi-India component. A Project Research Scientist position available in our #ImmunobiologyGroup at ICGEB New Delhi

Visit to the Institute for the Application of Nuclear Energy INEP University of Belgrade - parter of the MabTHER project Italy-Serbia for the production of therapeutic monoclonal antibodies - with Giulio Tarlao, Coordinator, Development Cooperation Activities and International Partnership #Regione Autonoma Friuli Venezia Giulia regione and Natasa Skoko, Head of Biotechnology Development at ICGEB 👉 https://lnkd.in/dRrEdaQv

A day of training was held at the ICGEB, during which researchers from the Cardiovascular Biology laboratory, headed by Serena Zacchigna, provided specific training on the use of flow cytometry and cell sorting to colleagues from the Slovenian partner #GaiaCell for the characterisation of adipose tissue cells. #Flowcytometry and #cell sorting are particularly relevant for the #Interreg #COHERENCE project, as they allow detailed characterisation of the various cell populations generated upon the expansion of patient’s primary cells, by labelling different membrane receptors with fluorescent markers. Specifically, endothelial cells and mesenchymal cells will be studied and characterised, for their eventual therapeutic use. 👉 https://lnkd.in/dQdYVWpp 🇮🇹🇸🇮